Literature DB >> 26850714

Eye movement abnormalities in a patient with Zellweger spectrum disorder.

F Rosini1, C Vinciguerra2, A Mignarri2, M Di Giovanni2, A Federico2, A Rufa3.   

Abstract

Entities:  

Keywords:  Eye movement abnormalities; Gaze-evoked nystagmus; Peroxisomal diseases; Zellweger spectrum disorders

Mesh：

Substances：

Year:  2016        PMID： 26850714     DOI： 10.1007/s10072-016-2499-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  4 in total

1.  Zellweger Spectrum Disorder with Mild Phenotype Caused by PEX2 Gene Mutations.

Authors:  Andrea Mignarri; Claudia Vinciguerra; Antonio Giorgio; Sacha Ferdinandusse; Hans Waterham; Ronald Wanders; Enrico Bertini; Maria Teresa Dotti; Antonio Federico
Journal:  JIMD Rep       Date:  2012-01-29

2.  Pendular nystagmus in patients with peroxisomal assembly disorder.

Authors:  A A Kori; N H Robin; J B Jacobs; D M Erchul; O O Zaidat; B F Remler; L Averbuch-Heller; L F Dell'Osso; R J Leigh; A B Zinn
Journal:  Arch Neurol       Date:  1998-04

3.  Visual follow-up in peroxisomal-disorder patients treated with docosahexaenoic Acid ethyl ester.

Authors:  M Teresa Noguer; Manuela Martinez
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

4.  Ocular-motor profile and effects of memantine in a familial form of adult cerebellar ataxia with slow saccades and square wave saccadic intrusions.

Authors:  Francesca Rosini; Pamela Federighi; Elena Pretegiani; Pietro Piu; R John Leigh; Alessandro Serra; Antonio Federico; Alessandra Rufa
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240
  4 in total
  2 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

Review 2.  Acquired pendular nystagmus.

Authors:  Sarah Kang; Aasef G Shaikh
Journal:  J Neurol Sci       Date:  2017-01-10       Impact factor: 3.181
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.